In conclusion, we presented a case of a young woman with locally advanced rectal adenocarcinoma with no histologic or immunohistochemical evidence of MMR deficiency but with NGS‐based identification of MSI in the setting of a missense MSH2 variant that allowed for appropriate immunotherapy with a sustained response. This evidence concerns the gene MRC1 and rectum adenocarcinoma.